We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleMDM2 amplification is an independent prognostic feature of node-negative, estrogen receptor-positive early-stage breast cancer.AuthorsChoschzick M; Heilenkötter U; Lebeau A; Jaenicke F; Terracciano L; Bokemeyer C; Sauter G; Simon RPublicationCancer biomarkers : section A of Disease markers, 2010, Vol 8, Issue 2, p53ISSN1875-8592Publication typearticleDOI10.3233/DMA-2011-0806